Never in modern times have such high hopes for millions of lives rested on one single company.

As the world struggles to fight off Covid-19, Gilead Sciences has been thrust in the spotlight with remdesivir, the antiviral drug that on Friday the Food and Drug Administration gave emergency authorization to treat coronavirus patients. Doctors are already preparing for a surge of requests from potential patients. Anthony Fauci, the nation’s top infectious disease expert, is sounding close to buoyant. The markets are showing signs of recovery. And President Trump, who has vilified the drug industry since before his election, welcomed Gilead CEO Daniel O’Day to the Oval Office.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • “Gilead’s mistake wasn’t the price itself, the executive said, but a failure to clearly explain to the public why Sovaldi was worth the money.”

    Oh, brother. If insanity is doing the same thing over and over expecting a different result, the measure of pharma’s insanity is its clinging to the “people-just-need-to-understand-the-value-of-medicines-and-then-they’ll-love-us” delusion.

    Repeat after me: people just need to be able to **afford** medicines.

  • We have people graduating from college who have been taught profits are evil. But ask them what will the motivation be to come up with a cure for other diseases and they just shrug their shoulders.

    The left is exploiting the Covid-19 panic in its long term goal of destroying capitalism. As Bernie Sanders has said…The pandemic “exposes the incredible weakness and dysfunctionality” of the U.S. health system; the cure is centralized, socialized care. Americans can’t get the drugs they need because “a bunch of crooks” run drug companies, “ripping us off every single day.”

    Government will save us? How’s that working out for Italy? Yet these claims are fantasy. Here’s the lesson of the virus so far: Relying solely on government bureaucracy is insane. To the extent America is weathering this moment, it is in enormous part thanks to the strength, ingenuity and flexibility of our thriving, competitive capitalist players.

Comments are closed.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy